CAS: 1459687-89-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GJ103 REF: IN-DA01E26HCAS: 1459687-89-8 | 98% | 228.00 €~339.00 € | Tue 10 Dec 24 |
 | GJ103 REF: TM-T3448CAS: 1459687-89-8 | 95.78% - 99.1% | 34.00 €~721.00 € | Tue 17 Dec 24 |
 | GJ-103 REF: 3D-JIC68789CAS: 1459687-89-8 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA01E26H
| 100mg | 228.00 € | ||
| 250mg | 339.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
GJ103
CAS:1459687-89-8
GJ103 sodium salt, an active GJ072 analog, shows read-through activity similar to RTC13/14 with better …
Formula:
C16H14N4O3S
Purity:
95.78% - 99.1%
Color and Shape:
Solid
Molecular weight:
342.37
Ref: TM-T3448
| 2mg | 34.00 € | ||
| 5mg | 50.00 € | ||
| 10mg | 84.00 € | ||
| 25mg | 149.00 € | ||
| 50mg | 174.00 € | ||
| 100mg | 213.00 € | ||
| 200mg | 259.00 € | ||
| 1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
GJ-103
CAS:1459687-89-8
GJ-103 is a novel drug that is used to treat licheniformis, a form of eczema. …
Formula:
C16H14N4O3S
Purity:
Min. 95%
Molecular weight:
342.37 g/mol
Ref: 3D-JIC68789
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
